Reinout van Crevel

tuberculosis researcher (ORCID 0000-0002-6233-6410)

Reinout van Crevel is …
instance of (P31):
humanQ5

External links are
P8446Gateway to Research person ID74EB61BE-2699-4B95-BFB7-BDCC5F67DDD5
P10283OpenAlex IDA5102841485
P496ORCID iD0000-0002-6233-6410
P1053ResearcherIDA-6636-2010

P185doctoral studentAyesha VerrallQ91250224
P734family namevan CrevelQ108004191
van CrevelQ108004191
van CrevelQ108004191
P735given nameReinoutQ2187196
ReinoutQ2187196
P106occupationresearcherQ1650915
P5008on focus list of Wikimedia projectNZThesisProjectQ111645234
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q31044800A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians
Q38363794Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus
Q35091998Active and latent tuberculosis among HIV-positive injecting drug users in Indonesia
Q125886143Adjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): Study protocol for a randomised controlled trial
Q46729405Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations
Q33986542Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia
Q43060160Application of spoligotyping to noncultured Mycobacterium tuberculosis bacteria requires an optimized approach
Q33280355Association of polymorphisms in IL-12/IFN-gamma pathway genes with susceptibility to pulmonary tuberculosis in Indonesia
Q37530766Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia
Q35377891Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer
Q30375629BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study.
Q38274692BCG-induced protection: effects on innate immune memory
Q37374103BCG-induced trained immunity in NK cells: Role for non-specific protection to infection
Q34300368Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
Q34552339Cerebral toxoplasmosis mimicking subacute meningitis in HIV-infected patients; a cohort study from Indonesia
Q48507319Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.
Q30888623Challenges in delivering HIV-care in Indonesia: experience from a referral hospital
Q30888427Characteristics of subjects counseled and tested for HIV in an Indonesian hospital; factors associated with HIV-status and CD4 cell-count.
Q36349886Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia
Q46057964Clinical experience with the combined use of lopinavir/ritonavir and rifampicin
Q35240921Clinical management of concurrent diabetes and tuberculosis and the implications for patient services
Q34055185Closing the policy-practice gap in the management of child contacts of tuberculosis cases in developing countries
Q34252123Common variants at 11p13 are associated with susceptibility to tuberculosis
Q34532738Comparison of real time IS6110-PCR, microscopy, and culture for diagnosis of tuberculous meningitis in a cohort of adult patients in Indonesia
Q38801426Correction for Bekkering et al., "In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes".
Q34376260Cost-effectiveness of methadone maintenance therapy as HIV prevention in an Indonesian high-prevalence setting: a mathematical modeling study
Q34667619Cost-effectiveness of scaling up voluntary counselling and testing in West-Java, Indonesia
Q33744330Costs and outcomes of VCT delivery models in the context of scaling up services in Indonesia
Q35794458Costs of HIV/AIDS treatment in Indonesia by time of treatment and stage of disease
Q34057772Cytokine production assays reveal discriminatory immune defects in adults with recurrent infections and noninfectious inflammation
Q30810448Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation
Q30234697Defining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 2: Underlying biological mechanisms
Q36453623Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids
Q33265416Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment
Q92926695Early Clearance of Mycobacterium tuberculosis Is Associated With Increased Innate Immune Responses
Q89968033Establishing the cascade of care for patients with tuberculous meningitis
Q43203258Evaluation of high- versus standard-dose rifampin in Indonesian patients with pulmonary tuberculosis
Q34561741Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes
Q37238784Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock
Q36783226GeneXpert MTB/Rif to Diagnose Tuberculous Meningitis: Perhaps the First Test but not the Last
Q21092470Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis
Q34430198Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis
Q37061098Harnessing the beneficial heterologous effects of vaccination
Q35094823Hepatitis B virus prevalence, risk factors and genotype distribution in HIV infected patients from West Java, Indonesia
Q35592853Heroin use in Indonesia is associated with higher expression of CCR5 on CD4+ cells and lower ex-vivo production of CCR5 ligands
Q28545281Heroin use is associated with suppressed pro-inflammatory cytokine response after LPS exposure in HIV-infected individuals
Q100752776High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)
Q40096008High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets
Q33653641High risk behavior for HIV transmission among former injecting drug users: a survey from Indonesia
Q61443141Immune cell characteristics and cytokine responses in adult HIV-negative tuberculous meningitis: an observational cohort study
Q37525436Immunometabolic Pathways in BCG-Induced Trained Immunity
Q34689226Implementation of LED fluorescence microscopy for diagnosis of pulmonary and HIV-associated tuberculosis in a hospital setting in Indonesia
Q33721305Implications of the global increase of diabetes for tuberculosis control and patient care
Q33287264Improved diagnosis of tuberculosis by better sputum quality
Q41160326Improvement of Depression and Anxiety After Discontinuation of Long- Term Efavirenz Treatment
Q30888729Improving diagnosis of pulmonary tuberculosis among HIV/AIDS patients: literature review and experience in a teaching hospital in Indonesia.
Q39298239In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes
Q30888678Indonesian prisons and HIV: part of the problem, part of the solution?
Q112642715Induction of trained immunity by influenza vaccination - impact on COVID-19
Q35081725Injecting drug use is associated with a more rapid CD4 cell decline among treatment naïve HIV-positive patients in Indonesia
Q34587177Innate immunity to Mycobacterium tuberculosis
Q30888477Integration of methadone maintenance treatment and HIV care for injecting drug users: a cohort study in Bandung, Indonesia
Q34458735Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial
Q45455937Interleukin-6 and human immunodeficiency virus load, but not plasma leptin concentration, predict anorexia and wasting in adults with pulmonary tuberculosis in Malawi
Q45492819Intravenous drug use and the spread of HIV; an international perspective
Q37296702Inverse relationship of serum hepcidin levels with CD4 cell counts in HIV-infected patients selected from an Indonesian prospective cohort study
Q33283091Iron deficiency and NRAMP1 polymorphisms (INT4, D543N and 3'UTR) do not contribute to severity of anaemia in tuberculosis in the Indonesian population
Q34729493Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients
Q89968037Knowledge gaps and research priorities in tuberculous meningitis
Q36349908Latent TB infection and pulmonary TB disease among patients with diabetes mellitus in Bandung, Indonesia
Q37620298Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity
Q40828543Long-term in vitro and in vivo effects of γ-irradiated BCG on innate and adaptive immunity
Q34327505Low cost HIV-1 quantitative RT-PCR assay in resource-limited settings: improvement and implementation
Q30555347Low induction of proinflammatory cytokines parallels evolutionary success of modern strains within the Mycobacterium tuberculosis Beijing genotype
Q35069064Management of children exposed to Mycobacterium tuberculosis: a public health evaluation in West Java, Indonesia
Q100693889Metformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits
Q40404556Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes
Q46653612More on tuberculosis.
Q42364862Moxifloxacin Is a Potent In Vitro Inhibitor of OCT- and MATE-Mediated Transport of Metformin and Ethambutol
Q33523135Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia
Q43124577Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1.
Q33374785Mycobacterium tuberculosis population structures differ significantly on two Indonesian Islands
Q24811631NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis
Q57176505Non-specific effects of vaccines: Current evidence and potential implications
Q46331629Numbers needed to treat to prevent tuberculosis
Q36104396Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients
Q33282527Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients
Q33521011Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes
Q114054838Plasma metabolome predicts trained immunity responses after antituberculosis BCG vaccination
Q34241113Polymorphisms in SP110 are not associated with pulmonary tuberculosis in Indonesians
Q34374038Polymorphisms in autophagy genes and susceptibility to tuberculosis
Q33527616Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains
Q35908648Predominance of modern Mycobacterium tuberculosis strains and active transmission of Beijing sublineage in Jayapura, Indonesia Papua
Q30888595Prevention and treatment of HIV addicted patients: a biopsychosocial approach
Q26851747Preventive therapy in children exposed to Mycobacterium tuberculosis: problems and solutions
Q42695119Reply to "strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response".
Q40072252Reply to Neeradi et al and Dhawan and Sankhyan
Q33544827Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia
Q37456438Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells
Q44092850Rifampicin and moxifloxacin for tuberculous meningitis--authors' reply
Q90429615Role of Glutamine Metabolism in Host Defense Against Mycobacterium tuberculosis Infection
Q35942752Routine or targeted HIV screening of Indonesian prisoners
Q34097635SNP/RD typing of Mycobacterium tuberculosis Beijing strains reveals local and worldwide disseminated clonal complexes
Q30888509Screening and diagnosis of HIV-infection in Indonesia: one, two or three tests?
Q33658539Sensitivity of the quantiferon-gold in-tube assay in sputum smear positive TB cases in Indonesia
Q34953130Severity of psychiatric and physical problems is associated with lower quality of life in methadone patients in Indonesia
Q40679421Sixty milligram daclatasvir is the right dose for hepatitis C virus treatment in combination with etravirine and darunavir/ritonavir
Q34537809Successful testing and treating of HIV/AIDS in Indonesia depends on the addiction treatment modality
Q91299310T Cell Metabolism Has Evolved to Tolerate Tuberculosis
Q39547504TANDEM: understanding diabetes and tuberculosis
Q24678506TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans
Q119684385The BNT162b2 mRNA Vaccine Against SARS-CoV-2 Reprograms Both Adaptive and Innate Immune Responses
Q35559840The C-type lectin receptor CLECSF8/CLEC4D is a key component of anti-mycobacterial immunity
Q33505477The effect of HIV infection on adult meningitis in Indonesia: a prospective cohort study
Q35558240The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with Mycobacterium tuberculosis
Q33291134The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis
Q30248586The global diabetes epidemic: what does it mean for infectious diseases in tropical countries?
Q34615423The influence of influenza virus infections on the development of tuberculosis
Q34740235The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study
Q38017483The role of autophagy in host defence against Mycobacterium tuberculosis infection
Q52606949Tissue metabolic changes drive cytokine responses to Mycobacterium tuberculosis.
Q34007595Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting
Q34172027Total lymphocyte count is a reliable surrogate marker for CD4 cell counts after the first year of antiretroviral therapy: data from an Indonesian cohort study.
Q114869936Trained Immunity as a Preventive Measure for Surgical Site Infections
Q95295198Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
Q104135153Trained immunity, tolerance, priming and differentiation: distinct immunological processes
Q38312182Trained immunity: consequences for the heterologous effects of BCG vaccination
Q38543488Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines
Q40402758Transmissible Mycobacterium tuberculosis Strains Share Genetic Markers and Immune Phenotypes.
Q33970633Treatment of knee prosthesis infections: evaluation of 15 patients over a 5-year period
Q38847398Unravelling the nature of non-specific effects of vaccines-A challenge for innate immunologists
Q34748343Virological failure and drug resistance during first line anti-retroviral treatment in Indonesia
Q35863177Women with HIV in Indonesia: are they bridging a concentrated epidemic to the wider community?

Q91250224Ayesha Verralldoctoral advisorP184
Q111965870Innate Factors in Early Clearance of Mycobacterium tuberculosisthesis committee memberP9161

Search more.